BerandaBLISSGVS • NSE
add
Bliss GVS Pharma Ltd
Tutup sebelumnya
₹163,84
Rentang hari
₹160,00 - ₹165,99
Rentang tahun
₹92,15 - ₹172,42
Kapitalisasi pasar
17,00Â M INR
Volume Rata-Rata
1,55Â jt
Rasio P/E
27,15
Hasil dividen
0,31%
Bursa utama
NSE
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 2,18Â M | 2,74% |
Biaya operasional | 682,58Â jt | 6,38% |
Laba bersih | 242,60Â jt | -42,66% |
Margin laba bersih | 11,14 | -44,22% |
Penghasilan per saham | — | — |
EBITDA | 414,11Â jt | -23,69% |
Tarif pajak efektif | 28,04% | — |
Neraca
Total aset
Total liabilitas
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,20Â M | 34,93% |
Total aset | 12,83Â M | 7,13% |
Total liabilitas | 2,34Â M | 0,06% |
Total ekuitas | 10,48 M | — |
Saham yang beredar | 105,02 jt | — |
Harga terhadap nilai buku | 1,70 | — |
Tingkat pengembalian aset | — | — |
Tingkat pengembalian modal | 7,68% | — |
Arus Kas
Perubahan kas bersih
| (INR) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 242,60Â jt | -42,66% |
Kas dari operasi | — | — |
Kas dari investasi | — | — |
Kas dari pembiayaan | — | — |
Perubahan kas bersih | — | — |
Arus kas bebas | — | — |
Tentang
Bliss GVS Pharma Limited is an Indian pharmaceutical company headquartered in Mumbai, India. Bliss GVS primarily develops, manufactures and markets products across various therapeutic categories including Anti-fungal, Contraceptive, Laxative, Anti-haemorrhoidal, Anti-spasmodic, Anti-malarial, Anti-biotic, Anti-microbial, Anti-inflammatory, Antipyretic, Analgesic and several others.
As of 31 March 2018, its market capitalization is INR 19.20 billion. Wikipedia
Didirikan
1984
Situs
Karyawan
831
